UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000030448
Receipt No. R000034765
Official scientific title of the study Low-power extracorporeal shock wave therapy for improvement of blood pressure and suppression of renal function reduction in CKD patients diagnosed as chronic kidney disease (CKD) stage 3, 4
Date of disclosure of the study information 2019/04/01
Last modified on 2017/12/18 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Low-power extracorporeal shock wave therapy for improvement of blood pressure and suppression of renal function reduction in CKD patients diagnosed as chronic kidney disease (CKD) stage 3, 4
Title of the study (Brief title) ESWT-CKD
Region
Japan

Condition
Condition CKD stage 3 &4 patients
Classification by specialty
Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 By using an extracorporeal shock wave device, we evaluate the effectiveness of low power extracorporeal shock wave therapy for improving blood pressure, an important risk factor of CKD progression, in CKD stage 3 &4 patients.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes improvement of mean blood pressure
Key secondary outcomes improvement of eGFR

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Extracorporeal Shock Wave
Interventions/Control_2 control
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria CKD stage 3 & 4 patients with at least one history of hypertension, diabetes, dyslipidemia, smoking history, cardiovascular complications
Key exclusion criteria Patients with a local skin infection at the contact site with the applicator
Patients with bleeding tendency
Patients with urolithiasis or kidney stones
Patients with hydronephrosis
Patients with active pyelonephritis
Patients with cancer
Patients treated with steroids or immunosuppressants
Patients who is expected to introduce dialysis within 12 weeks
Polycystic kidney disease patients
Patients with renal morphological abnormality
Patients who received kidney transplantation
Dialysis patients (HD, PD)
Patients whose renal blood flow cannot be evaluated
Objects considered by the attending physician as inappropriate
Target sample size 66

Research contact person
Name of lead principal investigator Yoshitaka Isaka
Organization Osaka University Graduate School of Medicine
Division name Nephrology
Address 2-2, Yamadaoka, Suita
TEL 0668793857
Email isaka@kid.med.osaka-u.ac.jp

Public contact
Name of contact person Yoshitaka Isaka
Organization Osaka University Graduate School of Medicine
Division name Nephrology
Address 2-2, Yamadaoka, Suita
TEL 0668793857
Homepage URL
Email isaka@kid.med.osaka-u.ac.jp

Sponsor
Institute Osaka University Graduate School of Medicine
Institute
Department

Funding Source
Organization Osaka University Graduate School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 04 Month 01 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 10 Month 01 Day
Anticipated trial start date
2018 Year 03 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 12 Month 18 Day
Last modified on
2017 Year 12 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034765